Systematic optimization of expression and refolding of the Plasmodium falciparum cysteine protease falcipain-2

被引:99
作者
Sijwali, PS
Brinen, LS
Rosenthal, PJ
机构
[1] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA
[2] San Francisco Gen Hosp, Dept Med, San Francisco, CA 94143 USA
关键词
D O I
10.1006/prep.2001.1416
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The Plasmodium falciparum cysteine protease falcipain-2 is a potential new target for antimalarial chemotherapy. In order to obtain large quantities of active falcipain-2 for biochemical and structural analysis, a systematic assessment of optimal parameters for the expression and refolding of the protease was carried out. High-yield expression was achieved using M15(pREP4) Escherichia coli transformed with the pQE-30 plasmid containing a truncated profalcipain-2 construct. Recombinant falcipain-2 was expressed as inclusion bodies, solubilized, and purified by nickel affinity chromatography. A systematic approach was then used to optimize refolding parameters. This approach utilized 100-fold dilutions of reduced and denatured falcipain-2 into 203 different buffers in a microtiter plate format. Refolding efficiency varied markedly. Optimal refolding was obtained in an alkaline buffer containing glycerol or sucrose and equal concentrations of reduced and oxidized glutathione. After optimization of the expression and refolding protocols and additional purification with anion-exchange chromatography, 12 mg of falcipain-2 was obtained from 5 liters of E. coli, and crystals of the protease were grown. The systematic approach described here allowed the rapid evaluation of a large number of expression and refolding conditions and provided milligram quantities of recombinant falcipain-2. (C) 2001 Academic Press.
引用
收藏
页码:128 / 134
页数:7
相关论文
共 45 条
[31]  
Rariy RV, 1999, BIOTECHNOL BIOENG, V62, P704, DOI 10.1002/(SICI)1097-0290(19990320)62:6<704::AID-BIT9>3.0.CO
[32]  
2-S
[33]   Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors [J].
Rosenthal, PJ ;
Olson, JE ;
Lee, GK ;
Palmer, JT ;
Klaus, JL ;
Rasnick, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (07) :1600-1603
[34]   ANTIMALARIAL EFFECTS OF PEPTIDE INHIBITORS OF A PLASMODIUM-FALCIPARUM CYSTEINE PROTEINASE [J].
ROSENTHAL, PJ ;
WOLLISH, WS ;
PALMER, JT ;
RASNICK, D .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05) :1467-1472
[35]   A MALARIAL CYSTEINE PROTEINASE IS NECESSARY FOR HEMOGLOBIN DEGRADATION BY PLASMODIUM-FALCIPARUM [J].
ROSENTHAL, PJ ;
MCKERROW, JH ;
AIKAWA, M ;
NAGASAWA, H ;
LEECH, JH .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 82 (05) :1560-1566
[36]   INHIBITION OF A PLASMODIUM-VINCKEI CYSTEINE PROTEINASE CURES MURINE MALARIA [J].
ROSENTHAL, PJ ;
LEE, GK ;
SMITH, RE .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (03) :1052-1056
[37]   In vitro folding of inclusion body proteins [J].
Rudolph, R ;
Lilie, H .
FASEB JOURNAL, 1996, 10 (01) :49-56
[38]   Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum [J].
Shenai, BR ;
Sijwali, PS ;
Singh, A ;
Rosenthal, PJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (37) :29000-29010
[39]  
SMITH SM, 1989, J BIOL CHEM, V264, P20487
[40]  
Suenaga M, 1998, BIOTECHNOL APPL BIOC, V28, P119